Translational Advances in Cancer Prevention Agent Development

Meeting Objectives

The main goals of this meeting are to:

  1. Foster the exchange of ideas and potentially new collaborative interactions among leading cancer prevention researchers from basic and clinical research,
     
  2. Highlight new and emerging trends in immunoprevention and chemoprevention as well as new information from clinical trials, and
     
  3. Highlight the significant resources available from the NCI to promote prevention agent development and rapid translation to clinical trials and to engage cancer researchers with novel prevention concepts.

Draft Agenda

Download Draft Agenda (DOC, 27 KB)

Meeting Organizers Contact Information

Mark Steven Miller, PhD
Program Director
National Cancer Institute
Email: mark.miller5@nih.gov
Phone: (240) 276-5004

Altaf Mohammed, PhD
Program Director
National Cancer Institute
Email: altaf.mohammed@nih.gov
Phone: (240) 276-6082

Date and Time: 

Thu, 08/27/2020 - 08:00 - Sat, 08/29/2020 - 12:00

Location: 

National Institutes of Health, Building 45, Natcher Conference Center, Bethesda, MD

Speaker(s): 

Various

Sponsor(s): 

Division of Cancer Prevention, National Cancer Institute